Mycosis fungoides is the commonest cutaneous T cell lymphoma. Clinically it is characterized by patch, plaque, tumour nodules; erythrodermic and poikilodermas stages which may overlap. Based on clinical symptoms, histology and immunostaining, these patients are then diagnosed with Mycosis Fungoides. As it has similar clinical features with other diseases so early diagnosis in these patients is often difficult. In patients with a history of chronic and progressive dermatosis, regular observation and repeat biopsy is necessary.

Radiation recall dermatitis (RRD) is an acute skin inflammatory reaction at previously irradiated area that is induced by the administration of certain agents after radiotherapy (Burris III, H. A., & Hurtig, J. 2010). Chemotherapeutic, non-chemotherapeutic agents and a few anti bacterials have been reported to induce RRD (Hird, A. E. et al., 2008). Tamoxifen and radiotherapy are used in breast cancer treatment all over the world. Here we report a case of radiation recall dermatitis induced by tamoxifen.

Mucositis is the breakdown of epithelial cells in the gastrointestinal tract. It is a common and painful side effect of treatment for many cancer patients. Oral cavity is a commonest site for mucositis however it can occur anywhere in the whole GI tract. Mucositis is very debilitating for patients and also lead to unwanted delays or dose reductions in life-saving treatments. Preventive strategies include good oral hygiene while treatment strategies mainly focus on the pain management. A stepwise treatment approach includes oral rinses, topical anaesthetics, and systemic analgesic agents.

dMycosis Fungoides is the commonest cutaneous T cell lymphoma. Clinically it is characterized by patch, plaque, tumour nodules; erythrodermic and poikilodermas stages which may overlap. Based on clinical symptoms, histology and immunostaining, these patients are then diagnosed with Mycosis Fungoides. As it has similar clinical features with other diseases so early diagnosis in these patients is often difficult. In patients with a history of chronic and progressive dermatosis, regular observation and repeat biopsy is necessary.

We report a case of 20 years old male with chondromyxoid fibroma antero-lateral aspect of left foot. The patient underwent wide local excision with extensor retinaculum repair with flap. Histopathological features suggestive of chondromyxoid fibroma and margins were involved, so patient was further taken up for local radiotherapy. 

Hand-foot syndrome (HFS) has been previously reported as a side effect in 45-56% of patients treated with capecitabine. In this study, we investigate the incidence, severity, and time course of HFS. Aim: Incidence and severity of Hand-Foot Syndrome (HFS) in patients with Colorectal carcinoma after giving capecitabine. Study Design: Toxicity data for 55 patients treated with capecitabine were analysed for the occurrence of HFS. Proportions of patients developing HFS after capecitabine treatment were calculated, and the severity and time course of HFS were analysed. This research is a retrospective study. Place and Duration of Study: This research was conducted at the Dr RPGMC, Tanda from October 2020 to April 2021. Results: 23 of the 45 patients had at least one episode of HFS. Most patients had their first or most severe episode of HFS after 2nd or 3rd cycles of treatment. 14 of the HFS episodes were grade 1 or 2; only 9 were grade 4. Conclusions: HFS is common in patients treated with capecitabine, and usually starts after 2 or 3 cycles of therapy.